EGFR  >>  Phase 2


12»
Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 02468101214161820
            
            
             
pimurutamab (HLX07) / Fosun Pharma           
          
            
             
SCT200 / Sinocelltech           
          
            
             
Hocena (antroquinonol) / Golden Biotechnology           
          
            
             
BMS690514 / BMS           
          
            
             
Tarlox (tarloxotinib bromide) / Pathos           
          
            
             
SYN004 / Synermore           
          
            
             
depatuxizumab (ABT-806) / AbbVie           
          
            
             
imgatuzumab (RO5083945) / Centessa           
          
            
             
matuzumab (EMD 72000) / Takeda, EMD Serono           
          
            
             
AC480 / BMS           
          
            
             
CDX-3379 / Celldex           
          
            
             
CUDC-101 / Curis           
          
            
             
D2C7 / Istari Oncology           
          
            
             
HA121-28 / CSPC Pharma           
          
            
             
duligotuzumab (MEHD7945A) / Roche           
          
            
             
AFM24 / Affimed           
          
            
             
Easyef (nepidermin) / Daewoong Pharma           
          
            
             
GC-1118A / GC Biopharma           
          
            
             
Irvalec (elisidepsin) / PharmaMar           
          
            
             
sutetinib (SZMD4) / Jiangsu Suzhong Pharma, Teligene           
          
            
             
AEE788 / Novartis           
          
            
             
BEBT-109 / BeBetter Med           
          
            
             
CetuGEX (tomuzotuximab) / Glycotope           
          
            
             
MCLA-129 / Merus           
          
            
             
MM-151 / Merrimack           
          
            
             
bafisontamab (EMB-01) / EpimAb Biotherap           
          
            
             
canertinib (CI-1033) / Pfizer           
          
            
             
pirotinib (KBP-5209) / Sihuan Pharmaceutical           
          
            
             
ABT-101 / Anbogen Therap           
          
            
             
BAT1006 / Bio-Thera Solutions           
          
            
             
BDTX-1535 / Black Diamond Therap           
          
            
             
BPI-361175 / Betta Pharma           
          
            
             
BTG-002814 / Boston Scientific           
          
            
             
CKD-702 / Chong Kun Dang           
          
            
             
CPGJ-602 / 3SBio           
          
            
             
EMD55900 / EMD Serono           
          
            
             
EO1001 / Apollomics           
          
            
             
H002 / Hongyun Biotech           
          
            
             
Heartcel (iMP cell therapy) / Celixir           
          
            
             
ORIC-114 / ORIC Pharma, Voronoi           
          
            
             
REGN7075 / Regeneron           
          
            
             
TAK-186 / Takeda           
          
            
             
allitinib (AST1306) / Allist           
          
            
             
keynatinib (TL007) / Medolution, Logix Pharma           
          
            
             
library TCR-T-cell therapy / Alaunos Therap           
          
            
             
multi-target gene-modified CAR-T/TCR-T cell immunotherapy / Shenzhen BinDeBio           
          
            
             
opolimogene capmilisbac (JNJ-64041809) / J&J           
          
            
             
pemlimogene merolisbac (JNJ-64041757) / Novartis           
          
            
             
petosemtamab (MCLA-158) / Merus           
          
            
             
tigozertinib (BLU-945) / Blueprint Medicines           
          
            
            


12»